These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9290769)

  • 1. Chronic rejection and graft arteriosclerosis: 4 years after the Alexis Carrel proposal on diagnostic criteria.
    Paul LC; Häyry P; Foegh M; Fellström B
    Transplant Proc; 1997 Sep; 29(6):2628-9. PubMed ID: 9290769
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs.
    Paul LC; Hayry P; Foegh M; Dennis MJ; Mihatsch MJ; Larsson E; Fellström B
    Transplant Proc; 1993 Apr; 25(2):2022-3. PubMed ID: 8470261
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic graft rejection: accelerated transplant arteriosclerosis.
    Ewel CH; Foegh ML
    Immunol Rev; 1993 Aug; 134():21-31. PubMed ID: 7693578
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. 4th Alexis Carrel Conference. Proceedings. Riksgränsen-Kiruna, Sweden, June 13-17, 1992.
    Transplant Proc; 1993 Apr; 25(2):2019-105. PubMed ID: 8097066
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.
    Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC
    Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is chronic rejection of liver transplants different from graft arteriosclerosis of kidney and heart transplants?
    Neil DA; Adams DH; Gunson B; Hubscher SG
    Transplant Proc; 1997 Sep; 29(6):2539-40. PubMed ID: 9290731
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the Vth International Alexis Carrel Conference. Genesis, prevention, diagnosis and treatment of chronic rejection, obliterative bronchiolitis and graft vessel disease after organ transplantation. Munich, Germany, June 22-24, 1994.
    Transplant Proc; 1995 Jun; 27(3):i-iii, 1921-2136. PubMed ID: 7792837
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of lipoprotein abnormalities in chronic vascular rejection after kidney transplantation.
    Dimény E; Fellström B; Larsson E; Walhberg J; Lithell H
    Transplant Proc; 1995 Jun; 27(3):2036-9. PubMed ID: 7792877
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis.
    Li F; Grauls G; Yin M; Bruggeman CA
    Transplant Proc; 1995 Dec; 27(6):3552-4. PubMed ID: 8540098
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic criteria of chronic rejection in transplanted hearts.
    Cary NR
    Transplant Proc; 1993 Apr; 25(2):2026-8. PubMed ID: 8470263
    [No Abstract]   [Full Text] [Related]  

  • 12. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart graft arteriosclerosis.
    Kosek JC; Bieber C; Lower RR
    Transplant Proc; 1971 Mar; 3(1):512-4. PubMed ID: 4937928
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection.
    Fellström B; Dimeny E; Larsson E; Klareskog L; Tufveson G; Rubin K
    Transplant Proc; 1989 Aug; 21(4):3689-91. PubMed ID: 2548309
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
    Adams DH; Tilney NL; Collins JJ; Karnovsky MJ
    Transplantation; 1992 May; 53(5):1115-9. PubMed ID: 1585476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation.
    Wilson RE
    Surg Gynecol Obstet; 1976 Feb; 142(2):219-24. PubMed ID: 1108247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renal transplantation and arteriosclerosis in the transplanted organ].
    Yamada K
    Nihon Jinzo Gakkai Shi; 2004; 46(8):789-91. PubMed ID: 15645734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Can we overcome chronic rejection?].
    Koskinen P; Nykänen A; Tikkanen J; Sihvola R; Krebs R; Lemström K
    Duodecim; 2004; 120(11):1401-9. PubMed ID: 15327093
    [No Abstract]   [Full Text] [Related]  

  • 19. Major histocompatibility complex class II antigen expression is suppressed by estradiol in cardiac allografts.
    Lou H; Kodama T; Wang YN; Katz NM; Ramwell PW; Foegh ML
    Transplant Proc; 1997 Sep; 29(6):2626-7. PubMed ID: 9290768
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
    Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.